Active	Status	Sponsor type	Region	Phase	Filter
6 Active 7 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Stella, Pieter
NCT02661451: Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)	Active, not recruiting	N/A	178	Europe, Canada, US	SAPIEN 3 THV, Optimal Heart Failure Therapy	Cardiovascular Research Foundation, New York, Cardialysis BV, Avania	Aortic Valve Stenosis	02/23	02/25
Thompson, Shayla
SGNS70-101, NCT04227847: A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies	Recruiting	1	140	Europe, US	SEA-CD70, azacitidine, VIDAZA	Seagen Inc.	Myelodysplastic Syndrome, Acute Myeloid Leukemia	12/24	11/26
NCT04903197: Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma	Active, not recruiting	1	18	Europe, Japan, RoW	VAY736, ianalumab, lenalidomide	Novartis Pharmaceuticals, Bristol-Myers Squibb	Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma	02/25	02/25
email, Taussig Research group
SGNS70-101, NCT04227847: A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies	Recruiting	1	140	Europe, US	SEA-CD70, azacitidine, VIDAZA	Seagen Inc.	Myelodysplastic Syndrome, Acute Myeloid Leukemia	12/24	11/26
Ackerman, Susan
NCT03926624: Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage	Recruiting	3	450	US	DFP-10917, Cytarabine, Azacitidine, Decitabine, Mitoxantrone, Etoposide, Fludarabine, Idarubicin, Venetoclax, Cladribine	Delta-Fly Pharma, Inc.	Leukemia, Myeloid, Acute	12/22	12/22
SGNS70-101, NCT04227847: A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies	Recruiting	1	140	Europe, US	SEA-CD70, azacitidine, VIDAZA	Seagen Inc.	Myelodysplastic Syndrome, Acute Myeloid Leukemia	12/24	11/26